When Brevin Cronk found himself in an emergency room last December, his blood-oxygen level was 77% and his lips had turned blue. It was soon determined by the team at UW Medical Center in Seattle that a transcatheter repair was necessary—and virtual reality (VR) played a key role in Cronk’s care.
HHS is extending its existing partnership with pharmaceutical company Janssen Research & Development, which is part of Johnson & Johnson, to develop treatments for the 2019 novel coronavirus, the agency announced.
More Americans afflicted with chronic disease are turning to unregulated markets such as Craigslist to find insulin and other necessary medications because they can’t afford to purchase them at the pharmacy.
Robot-assisted bronchoscopies (RABs) are “safe and feasible,” according to new findings published in BMC Pulmonary Medicine. Will this breakthrough lead to improvements in patient care?
A Medicare for all healthcare system has the potential to improve the availability of services and efficiency of care in the United States, according to a recent study published in The Lancet.
As the world waits and watches to see what the coronavirus does next, the bad old flu is getting a second wind in the U.S.—and children may be bearing the brunt.
HCCI analyzed more than 2.5 billion de-identified claims, including those for prescription drugs as well as medical visits, filed from 2014 to 2018 with Aetna, Humana, Kaiser Permanente and UnitedHealthcare.
Researchers have used AI technology to predict a patient’s chance of death, heart attack or stroke better than human doctors, sharing their findings in a new study in Circulation.
